Disulfide With Human Humax-axl .kappa.-chain
Disulfide With Human Humax-axl .kappa.-chain Uses, Dosage, Side Effects, Food Interaction and all others data.
Disulfide With Human Humax-axl .kappa.-chain is under investigation in clinical trial NCT02988817 (Enapotamab Vedotin (Humax-axl-adc) Safety Study in Patients With Solid Tumors).
Trade Name | Disulfide With Human Humax-axl .kappa.-chain |
Generic | Enapotamab vedotin |
Enapotamab vedotin Other Names | Enapotamab vedotin, Humax axl adc, HuMax-AXL-ADC, Immunoglobulin g1, anti-(human growth factor receptor axl)(human humax-axl .gamma.1-chain), disulfide with human humax-axl .kappa.-chain, dimer tetrakis(thioether) with vedotin |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
![Disulfide With Human Humax-axl .kappa.-chain Disulfide With Human Humax-axl .kappa.-chain](https://www.medicinesfaq.com/media/png/disulfide-with-human-humax-axl-.kappa.-chain.png)
Innovators Monograph
You find simplified version here Disulfide With Human Humax-axl .kappa.-chain